Research
Hormonal
Incretin drug therapy can produce significant weight loss in properly selected individuals.
Clinicians should consider incretin therapy for weight loss in appropriately selected patients.
StrongSupportsmedium confidence
Incretin drug therapy can produce significant weight loss in properly selected individuals.
Why this rating
The claim is based on a narrative review of relevant literature.
Source
Incretins for obesity: closer to a nicotine patch than a silver bullet
Isabella Dippel et al. · Expert Opinion on Pharmacotherapy · 2025
DOI 10.1080/14656566.2025.2557458
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →